Analytical Data
-
Gene name
STK17B
- Application
-
Alternative Names
STK17B；DRAK2；Serine/threonine-Protein kinase 17B
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O94768
-
Expression Region
1-372aa
-
AA Sequence
MSRRRFDCRSISGLLTTTPQIPIKMENFNNFYILTSKELGRGKFAVVRQC ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN LFHPEETSSSSQTQDHSVRSSEDKTSKSSCNGTCGDREDKENIPEDSSMV SKRFRFDDSLPNPHELVSDLLC
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STK17B, or serine/threonine kinase 17B, is a member of the serine/threonine kinase family, which plays a significant role in various cellular processes, including apoptosis, autophagy, and stress response. Research on STK17B has gained attention due to its involvement in several pathological conditions, such as cancer, neurodegenerative diseases, and inflammatory disorders. The protein is known to interact with multiple signaling pathways, and its dysregulation may contribute to disease progression. Given this context, the study of STK17B recombinant proteins has become a crucial area of investigation, facilitating the understanding of its biological functions and potential as a therapeutic target. By producing STK17B in a recombinant form, researchers can examine its activity, structure-function relationships, and interactions with other cellular proteins in a controlled environment. This research not only enhances our knowledge of STK17B's biological role but also opens pathways for drug development aimed at modulating its activity. As a result, the exploration of STK17B recombinant proteins is essential for advancing our comprehension of its implications in health and disease.
